E. Eigendorff
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in ⓘ
-
- Lung Cancer Diagnosis and Treatment 5
- Lung Cancer Treatments and Mutations 2
- Oncology 6
- Cancer Immunotherapy and Biomarkers 5
- Cancer Diagnosis and Treatment 2
- Co-authors
- Heather A. Wakelee (5 shared papers)Terufumi Kato (5 shared papers)Olivier Bylicki (5 shared papers)Ayman Samkari (4 shared papers)Moïshe Liberman (5 shared papers)Gastón Lucas Martinengo (4 shared papers)Margarita Majem (4 shared papers)Jamie E. Chaft (4 shared papers)
- Journals
- Annals of Oncology (3 papers)Hormone and Metabolic Research (2 papers)Journal of Clinical Oncology (2 papers)Journal of Thoracic Oncology (1 paper)Journal of Endocrinology (1 paper)
- Partner nations
- GermanyUnited StatesJapan
In The Last Decade
E. Eigendorff
11 papers receiving 697 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Pulmonary and Respiratory Medicine 466
- Oncology 379
- Endocrinology, Diabetes and Metabolism 107
- Behavioral Neuroscience 15
- Cancer Research 55
Countries citing papers authored by E. Eigendorff
This map shows the geographic impact of E. Eigendorff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Eigendorff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Eigendorff more than expected).
Fields of papers citing papers by E. Eigendorff
This network shows the impact of papers produced by E. Eigendorff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Eigendorff. The network helps show where E. Eigendorff may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Eigendorff, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer Hit paper breakdown → | 2023 | 460 |
| 2 | 2002 | 123 | |
| 3 | 2023 | 51 | |
| 4 | 2004 | 21 | |
| 5 | 2020 | 18 | |
| 6 | 2023 | 11 | |
| 7 | 2003 | 8 | |
| 8 | 2024 | 5 | |
| 9 | 2010 | 4 | |
| 10 | 2024 | 2 | |
| 11 | 2016 | 1 |
About E. Eigendorff
E. Eigendorff is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Endocrinology, Diabetes and Metabolism, Surgery and Genetics, having authored 11 papers that have together received 704 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Hormonal Regulation and Hypertension (4 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer Diagnosis and Treatment (2 papers), Estrogen and related hormone effects (2 papers), Adrenal Hormones and Disorders (2 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (466 citations), Oncology (379 citations), Endocrinology, Diabetes and Metabolism (107 citations), Behavioral Neuroscience (15 citations) and Cancer Research (55 citations). E. Eigendorff has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Heather A. Wakelee, Terufumi Kato, Olivier Bylicki, Ayman Samkari, Moïshe Liberman, Gastón Lucas Martinengo, Margarita Majem, Jamie E. Chaft, Delvys Rodríguez‐Abreu and Christophe Dooms. Their work appears in journals such as Annals of Oncology, Hormone and Metabolic Research, Journal of Clinical Oncology, Journal of Thoracic Oncology and Journal of Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.